Skip to main content
Clinical Trials/DRKS00008721
DRKS00008721
Completed
Not Applicable

Quality of life and treatment satisfaction with conventional systemic therapy in patients with psoriasis vulgaris - an observational study.

niversitätsklinikum Heidelberg0 sites60 target enrollmentOctober 19, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
L40.0
Sponsor
niversitätsklinikum Heidelberg
Enrollment
60
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 19, 2015
End Date
March 31, 2016
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Heidelberg

Eligibility Criteria

Inclusion Criteria

  • Patients with plaque psoriasis who begin therapy with a conventional systemic drug (Apremilast, methotrexate or Fumaderm) at the Department of Dermatology at the University of Heidelberg.
  • Patients must be at least 18 years old and give their written consent for study participation.

Exclusion Criteria

  • Patients who are younger than 18 years of age, or are not fluent of the German language.
  • Furthermore, patients with psychiatric diagnoses are excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials